Figure 6
Figure 6. Ex vivo expansion and colony-forming potential of peripheral blood CD34+ cells after treatment with TAT-NF-Ya. Human peripheral blood CD34+ cells were treated with TAT-NF-Ya (or not treated) for 1.5 hours and then cultured for 30 days in serum-free media supplemented with Flt-3/Flk-2L, SCF, thrombopoietin (100 ng/mL each), and IL-3 and IL-6 (20 ng/mL each). Total mononuclear cells (A) were counted; the number of colony-forming erythroid (ER indicates BFU-E), CFU-GM, and CFU-GEMM were measured by methylcellulose assays (B), and the relative contribution to the progenitor cell pool of each class of progenitors calculated (C).

Ex vivo expansion and colony-forming potential of peripheral blood CD34+ cells after treatment with TAT-NF-Ya. Human peripheral blood CD34+ cells were treated with TAT-NF-Ya (or not treated) for 1.5 hours and then cultured for 30 days in serum-free media supplemented with Flt-3/Flk-2L, SCF, thrombopoietin (100 ng/mL each), and IL-3 and IL-6 (20 ng/mL each). Total mononuclear cells (A) were counted; the number of colony-forming erythroid (ER indicates BFU-E), CFU-GM, and CFU-GEMM were measured by methylcellulose assays (B), and the relative contribution to the progenitor cell pool of each class of progenitors calculated (C).

Close Modal

or Create an Account

Close Modal
Close Modal